Moderna Covid-19 vaccine shows 94.1 per cent efficacy in trial: Study – Times of India
NEW DELHI: Results from the primary analysis of the ongoing phase 3 clinical trial of US biotechnology company Moderna's Covid-19 vaccine have revealed 94.1 per cent efficacy of the therapeutic in preventing symptomatic infections and…